Vaccination as immunotherapy for B cell
โ
Joachim L. Schultze
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 161 KB
Current therapy does not cure the majority of patients with B cell non-Hodgkin's lymphoma (NHL) and further intensification does not benefit the patient. Therefore, new approaches are necessary. Immunotherapy has become again a major interest as a new treatment modality for B cell lymphoma since the